Evotec is able to offer screening services for biochemical, functional and/or cellular responses using its proprietary high throughput screening (HTS) technology (FCS+plus) and/or other commercial platforms. This can be through providing access to its own 250,000 compound screening library or using the client's library of compounds.
Evotec’s offering:
- Biochemical, functional and cellular screening
- High content screening and high content analysis
- Label-free screening (NMR, SPR, LC-MS)
- Fragment based screening
- Compound profiling
- In vitro ADMET assays
Benefits to the partner:
- Superior detection technology and increased assay sensitivity resulting in higher quality data and less false positives and false negatives
- Assay miniaturization resulting in the use of less protein giving lower costs and faster lead-times to initiating screens
- Multiple readout parameters further enabling the reduction in false positives and negatives and providing high quality assay statistics resulting in the ability to screen highly challenging targets
- Strong track record in developing assays for HTS for numerous target classes (Ion Channels, GPCRs, Kinases, Nuclear Hormone Receptors, Proteases & Other Enzymes, Protein-Protein Interactions)
For more information, please contact us at info@evotec.com